This record was last updated December 10, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.
Protocol Amendment History
4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-12-03; most recent amendment 2025-12-03.
Status change: Not Yet Recruiting → Recruiting2025-01-21